Clearside’s wet AMD drug-device combo shines in Phase IIb study

Clearside’s wet AMD drug-device combo shines in Phase IIb study

Submitted by admin on October 11, 2024 - 9:40am
Source: 
Clinical Trials Arena
News Tags: 
Clearside Biomedical
clinical trials
wet age-related macular degeneration
CLS-AX
drug-device combos
FDA
Headline: 
Clearside’s wet AMD drug-device combo shines in Phase IIb study
snippet: 

Clearside is now looking at a Phase III trial as it plans to meet with the FDA early next year to discuss the new Phase IIb topline results.

Do Not Allow Advertisers to Use My Personal information